Characteristics, treatment and outcome of patients with hepatocellular carcinoma (HCC) in the United States: An analysis of 328 patients from 1998-2005

被引:0
|
作者
Stadler, Z. K.
Stuart, K. E.
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Lahey Clin Fdn, Burlington, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4615
引用
收藏
页数:1
相关论文
共 50 条
  • [41] HEALTHCARE COSTS AND EXPENDITURES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Karim, Mohammad
    Ramezani, Mahin
    Leroux, Todd
    Kum, Hye Chung
    Singal, Amit G.
    HEPATOLOGY, 2022, 76 : S1392 - S1392
  • [42] Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States
    Karim, Mohammad A.
    Ramezani, Mahin
    Leroux, Todd
    Kum, Hye-Chung
    Singal, Amit G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2327 - +
  • [43] Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States
    Yang, Baiyu
    Shebl, Fatma M.
    Sternberg, Lawrence R.
    Warner, Andrew C.
    Kleiner, David E.
    Edelman, Daniel C.
    Gomez, Allison
    Dagnall, Casey L.
    Hicks, Belynda D.
    Altekruse, Sean F.
    Hernandez, Brenda Y.
    Lynch, Charles F.
    Meltzer, Paul S.
    McGlynn, Katherine A.
    PLOS ONE, 2016, 11 (11):
  • [44] Impact of lymph node metastases on outcome following treatment with sorafenib in patients with hepatocellular carcinoma (HCC): Subset analysis from the phase III SHARP trial
    Raoul, J.
    Craxi, A.
    Porta, C.
    Lentini, G.
    Nadel, A.
    Voliotis, D.
    Bruix, J.
    Llovet, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Demographic, epidemiological and clinical characteristics of patients with hepatocellular carcinoma (HCC) in Southeastern Europe
    Kypreos, D.
    Saribeyoglou, N.
    Theodoropoulos, L.
    Hatzinikolaou, M.
    Malahias, A.
    Stavrinidis, S.
    Tsamakidis, K.
    Xinopoulos, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 183 - 183
  • [46] Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study
    Gawrieh, Samer
    Dakhoul, Lara
    Miller, Ethan
    Scanga, Andrew
    DeLemos, Andrew
    Kettler, Carla
    Burney, Heather
    Liu, Hao
    Abu-Sbeih, Hamzah
    Chalasani, Naga
    Wattacheril, Julia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (07) : 809 - 821
  • [47] The Risk Factors of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Chronic Hepatitis B Patients in United States Veterans
    Chayanupatkul, Maneerat
    Omino, Ronald
    Mittal, Sahil
    Kramer, Jennifer R.
    Richardson, Peter
    El-Serag, Hashem B.
    Kanwal, Fasiha
    GASTROENTEROLOGY, 2016, 150 (04) : S4 - S4
  • [48] TRENDS IN TREATMENT OF HEPATOCELLULAR CARCINOMA: ANALYSIS OF A NATIONWIDE INPATIENT DATABASE FROM THE UNITED STATES
    Abbas, A.
    Shores, N.
    Medvedev, Sabeen
    Bazzano, L.
    Medvedev, Sofia
    Balart, L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S270 - S271
  • [49] Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States
    Poklepovic, A. S.
    Sanyal, A.
    Moyneur, E.
    Meyers, S.
    Barghout, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
    Bengtsson, Bonnie
    Stal, Per
    Wahlin, Staffan
    Bjorkstrom, Niklas K.
    Hagstrom, Hannes
    LIVER INTERNATIONAL, 2019, 39 (06) : 1098 - 1108